These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2406205)

  • 41. Endogenous type I interferons as a defense against tumors.
    Gresser I; Belardelli F
    Cytokine Growth Factor Rev; 2002 Apr; 13(2):111-8. PubMed ID: 11900987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth inhibition of Friend erythroleukaemia cell tumours in vivo by a synthetic analogue of prostaglandin A: an action independent of natural killer-activity.
    Marini S; Palamara AT; Garaci E; Santoro MG
    Br J Cancer; 1990 Mar; 61(3):394-9. PubMed ID: 2328205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulation of genetic resistance to marrow grafts in mice by interferon-alpha/beta.
    Afifi MS; Kumar V; Bennett M
    J Immunol; 1985 Jun; 134(6):3739-45. PubMed ID: 2985694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IFN-alpha 1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice.
    Kaido T; Bandu MT; Maury C; Ferrantini M; Belardelli F; Gresser I
    Int J Cancer; 1995 Jan; 60(2):221-9. PubMed ID: 7829220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-1 beta induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor alpha or beta.
    Belardelli F; Proietti E; Ciolli V; Sestili P; Carpinelli G; Di Vito M; Ferretti A; Woodrow D; Boraschi D; Podo F
    Int J Cancer; 1989 Jul; 44(1):116-23. PubMed ID: 2787294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcriptional induction of H2 (class I) antigens and beta 2 microglobulin by interferon-gamma in interferon-sensitive and interferon-resistant Friend leukemia cells.
    Coccia E; Marziali G; Fiorucci G; Romeo G; Affabris E; Battistini A; Rossi GB
    J Biol Regul Homeost Agents; 1992; 6(1):21-5. PubMed ID: 1442172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of murine interferon-alpha/beta on an established Rauscher murine leukemia virus-induced erythroleukemia in BALB/c mice.
    Hekman RA; Trapman J
    Int J Cancer; 1985 Apr; 35(4):515-20. PubMed ID: 2580803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Susceptibility of Friend virus antigen-modulated erythroleukemic cells to lysis by T lymphocytes from mice with dormant Friend virus infections.
    Genovesi EV; Marx PA; Wheelock EF
    J Immunol; 1979 Mar; 122(3):795-800. PubMed ID: 312825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor necrosis factor alpha induces early morphologic and metabolic alterations in Friend leukemia cell tumors and fibrosarcomas in mice.
    Proietti E; Belardelli F; Carpinelli G; Di Vito M; Woodrow D; Moss J; Sestili P; Fiers W; Gresser I; Podo F
    Int J Cancer; 1988 Oct; 42(4):582-91. PubMed ID: 3170030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors.
    Gresser I; Belardelli F; Maury C; Maunoury MT; Tovey MG
    J Exp Med; 1983 Dec; 158(6):2095-107. PubMed ID: 6644239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-tumor effects of interleukin-2 and interleukin-1 in mice transplanted with different syngeneic tumors.
    Belardelli F; Ciolli V; Testa U; Montesoro E; Bulgarini D; Proietti E; Borghi P; Sestili P; Locardi C; Peschle C
    Int J Cancer; 1989 Dec; 44(6):1108-16. PubMed ID: 2606579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Staurosporine inhibits interferon alpha-induced gene expression in Friend erythroleukemia cells through a PKC independent pathway.
    Percario ZA; Fiorucci G; Marcolin C; Mangino G; Affabris E; Romeo G
    J Biol Regul Homeost Agents; 1995; 9(1):7-14. PubMed ID: 8553907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of genetic resistance to friend virus leukemia in mice.
    Kumar V; Bennett M; Eckner RJ
    J Exp Med; 1974 May; 139(5):1093-109. PubMed ID: 4596510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. I.
    Belardelli F; Gresser I; Maury C; Maunoury MT
    Int J Cancer; 1982 Dec; 30(6):813-20. PubMed ID: 6186614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of serum from mice with dormant Friend leukemia viral infections on synthesis and modulation of erythroleukemia cell surface gp70.
    Callahan RM; Marx PA; Marum WG; Wheelock EF
    J Immunol; 1980 Aug; 125(2):616-22. PubMed ID: 6930443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The spleen in Friend leukemia. I. Prolonged survival of leukemic mice after autoimplantation of spleen tissue.
    Levy SB; Rubenstein CB; Friend C
    J Natl Cancer Inst; 1976 Jun; 56(6):1183-8. PubMed ID: 1069138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Susceptibility of BALB/c mice carrying various DBA/2 genes to development of Friend murine leukemia virus-induced erythroleukemia.
    Ruscetti S; Matthai R; Potter M
    J Exp Med; 1985 Nov; 162(5):1579-87. PubMed ID: 3863879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V
    Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth properties, differentiation capacity and oncogene expression in metastatic and nonmetastatic Friend leukemia cell variants.
    Sala A; Benedetto A; Elia G; Pulciani S; Ciotta C; Parlanti E; Santodonato L; Belardelli F
    Invasion Metastasis; 1991; 11(4):192-203. PubMed ID: 1765432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biologic and biochemical differences between in vitro and in vivo passaged Friend erythroleukemia cells. II. Changes in cell surface glycoproteins associated with a highly malignant phenotype.
    Amici C; Ferrantini M; Benedetto A; Belardelli F; Gresser I
    Int J Cancer; 1984 Sep; 34(3):397-402. PubMed ID: 6480157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.